CLINSIS SALON SARL – Trademark Portfolio

Entity Type: 03

CLINSIS SALON SARL holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CLINSIS. The owner is based in Paris.

8 rue du Faubourg Poissonnière

Paris 75010 , FR

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CLINSIS
CLINSIS
Registered 2024
CLINSIS
CLINSIS
Registered 2024

Trademark Classifications

CLINSIS SALON SARL's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does CLINSIS SALON SARL have?

CLINSIS SALON SARL has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does CLINSIS SALON SARL file in?

CLINSIS SALON SARL files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning). Class 35 covers advertising; business management; business administration; office functions.

What are CLINSIS SALON SARL's most well-known trademarks?

CLINSIS SALON SARL's registered trademark portfolio includes well-known marks such as CLINSIS. These are among 2 currently registered trademarks in the portfolio.

What is CLINSIS SALON SARL's trademark registration success rate?

CLINSIS SALON SARL has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.